baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ACASTI PHARMA INC/ CA00430K8730 /

2023-03-27 5:24:42 PM	Chg. -	Volume	Bid10:16:06 PM	Ask10:16:06 PM	High	Low
0.58CAD	-	2,450 Turnover: 1,130	0.58Bid Size: 3,000	0.98Ask Size: 500	0.58	0.56

GlobeNewswire 02-12 Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 02-01 Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

GlobeNewswire 2023-12-13 Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024

GlobeNewswire 2023-11-13 Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 2023-10-23 Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial

GlobeNewswire 2023-10-04 Acasti Pharma to Host KOL Event on GTX-104: A Potential New Treatment Standard for Rare and Life-Thr...

GlobeNewswire 2023-09-26 Acasti Announces $7.5 Million Private Placement Equity Financing

GlobeNewswire 2023-09-06 Acasti to Participate in the H.C. Wainwright Global Investment Conference

Newsfile Corp 2023-01-17 Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3...

Newsfile Corp 2022-09-21 Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day ...

Newsfile Corp 2022-07-07 Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day P...

GlobeNewswire 2022-03-25 Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors

GlobeNewswire 2022-03-22 Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan

GlobeNewswire 2022-03-09 Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th

GlobeNewswire 2022-02-28 Acasti Pharma Celebrates Rare Disease Day

Newsfile Corp 2022-02-22 Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast

GlobeNewswire 2022-02-14 Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

GlobeNewswire 2022-02-07 Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call

GlobeNewswire 2022-01-03 Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

GlobeNewswire 2021-12-02 Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

GlobeNewswire 2021-11-24 Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

GlobeNewswire 2021-11-12 Acasti Pharma Announces Annual Stock Option Grants

Newsfile Corp 2021-11-11 Acasti Pharma To Present At The Q4 Investor Summit on November 16th

GlobeNewswire 2021-11-10 Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022

Newsfile Corp 2021-11-08 Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit

ACASTI PHARMA INC/ CA00430K8730 /

If you wish to receive reply to your feedback, please provide your email address.